Author

Mark J. Routbort

The University of Texas MD Anderson Cancer CenterORCID 0000-0003-4860-261XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Farhad RavandiiD· 2 shared Andrea LagansoniD· 1 shared Andrew J. CarrolliD· 1 shared Andrew R. StiffiD· 1 shared Ann‐Kathrin EisfeldiD· 1 shared Bayard L. Powell· 1 shared Caleb A. Class· 1 shared Carlos E. Bueso-Ramos· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Farhad RavandiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyLeukemiaPeer-reviewedJun 15, 2026

Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid Leukemia

Darren Lee, Yazan Abu-Shihab, Kate Plas…·Linde A. Miles

This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.

DOI 10.1038/s41375-026-02996-1

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 8, 2020

Evolutionary Action Score of TP53 Mutations: Integrated Clinico-pathologic And Protein Structural Analysis in Myelodysplastic Syndromes

Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis…·Guillermo Garcia-Manero

The paper quantifies the impact of TP53 mutations in myelodysplastic syndromes using an evolutionary action score and correlates it with clinical and genomic features, finding that low-EAp53 mutations are associated with better survival.

DOI 10.1101/2020.07.08.194365

humanbulk RNA-seq

𝕏 PostBluesky